| William Miller, MD | |
|
3433 Nw 56th St, Oklahoma City, OK 73112-4455 | |
| (405) 949-2322 | |
| (405) 949-2496 |
| Full Name | William Miller |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 44 Years |
| Location | 3433 Nw 56th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811988835 | NPI | - | NPPES |
| 100110890A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 13146 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
| Integris Canadian Valley Hospital | Yukon, OK | Hospital |
| Integris Southwest Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Specialists Of Central Oklahoma Llc | 0042474371 | 5 |
News Archive
Noninvasive Medical Technologies, Inc. (NMT), an award-winning company engaged in pioneering highly advanced remote patient monitoring solutions, today announced that it has been awarded ISO 13485 certification of its quality management systems for the design and manufacture of safe and effective medical devices.
AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.
Scientists at the Dana-Farber Cancer Institute may have uncovered a mechanism for blocking tumor angiogenesis that involves the patient's immune system, according to findings published in Cancer Research, a journal of the American Association for Cancer Research.
CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2011.
› Verified 2 days ago
| Entity Name | Urology Specialists Of Central Oklahoma Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356612063 PECOS PAC ID: 0042474371 Enrollment ID: O20120615000549 |
News Archive
Noninvasive Medical Technologies, Inc. (NMT), an award-winning company engaged in pioneering highly advanced remote patient monitoring solutions, today announced that it has been awarded ISO 13485 certification of its quality management systems for the design and manufacture of safe and effective medical devices.
AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.
Scientists at the Dana-Farber Cancer Institute may have uncovered a mechanism for blocking tumor angiogenesis that involves the patient's immune system, according to findings published in Cancer Research, a journal of the American Association for Cancer Research.
CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2011.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Miller, MD 3433 Nw 56th St Ste 910, Oklahoma City, OK 73112-4430 Ph: (405) 949-2322 | William Miller, MD 3433 Nw 56th St, Oklahoma City, OK 73112-4455 Ph: (405) 949-2322 |
News Archive
Noninvasive Medical Technologies, Inc. (NMT), an award-winning company engaged in pioneering highly advanced remote patient monitoring solutions, today announced that it has been awarded ISO 13485 certification of its quality management systems for the design and manufacture of safe and effective medical devices.
AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.
Scientists at the Dana-Farber Cancer Institute may have uncovered a mechanism for blocking tumor angiogenesis that involves the patient's immune system, according to findings published in Cancer Research, a journal of the American Association for Cancer Research.
CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2011.
› Verified 2 days ago
Dr. Jeremy Alex Davis, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 13509 N Meridian Ave Ste 6, Oklahoma City, OK 73120 Phone: 405-768-1180 Fax: 405-768-1181 | |
Barbara L Voss-alvarez, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 11000 Hefner Pointe Dr, Oklahoma City, OK 73120 Phone: 405-749-9655 Fax: 405-749-1001 | |
Rajendra K. Motwani, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 9817 S Western Ave, Oklahoma City, OK 73139 Phone: 405-632-4500 Fax: 405-632-7500 | |
Richard E Herlihy, MD Urology Medicare: May Accept Medicare Assignments Practice Location: 4140 W Memorial Rd, Suite 611, Oklahoma City, OK 73120 Phone: 405-749-4288 Fax: 405-749-4287 | |
Daniel J Culkin, MD Urology Medicare: Medicare Enrolled Practice Location: 825 Ne 10th St, Oupb5400, Oklahoma City, OK 73104 Phone: 405-271-6452 | |
Dr. Brian Alan Link, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4140 W Memorial Rd, Suite 518, Oklahoma City, OK 73120 Phone: 405-749-4230 Fax: 405-749-4228 | |
Amber Bauer, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 920 Stanton L Young Blvd # Wp3150, Oklahoma City, OK 73104 Phone: 405-271-6900 |